$ICGN Icagen, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Icagen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Icagen, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Icagen, Inc. for free.
IRS Number: 200982060
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: ICGN
Company Address: 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM 27703
Phone number: 919-941-5206
Former name: Caldera Pharmaceuticals Inc, date of change: 2011-04-19
Former name: XRpro Sciences, Inc., date of change: 2014-12-04
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
Icagen, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28 2019 | ICGN | Icagen, Inc. | TAGLICH ROBERT | 10% Owner | Option Exercise | A | 3.50 | 71,428 | 249,998 | 114,285 | |
| Aug 28 2019 | ICGN | Icagen, Inc. | TAGLICH ROBERT | 10% Owner | Option Exercise | A | 3.50 | 71,428 | 249,998 | 71,428 | |
| Aug 28 2019 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 71,428 | 249,998 | 114,285 | |
| Aug 28 2019 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 71,428 | 249,998 | 71,428 | |
| May 01 2019 | ICGN | Icagen, Inc. | Cunningham, Richard Anthony | Chief Executive Off ... | Option Exercise | A | 3.50 | 154,616 | 541,156 | 154,616 | |
| May 01 2019 | ICGN | Icagen, Inc. | Krafte Douglas | Chief Scientific Of ... | Option Exercise | A | 3.50 | 75,267 | 263,435 | 75,267 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | Cunningham, Richard Anthony | Chief Executive Off ... | Option Exercise | A | 3.50 | 535,000 | 1,872,500 | 535,000 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | KORB MARK JOHN | Chief Financial Off ... | Option Exercise | A | 3.50 | 100,000 | 350,000 | 100,000 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | Krafte Douglas | Chief Scientific Of ... | Option Exercise | A | 3.50 | 120,000 | 420,000 | 120,000 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | Roffman Edward | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 100,000 | 350,000 | 100,000 | |
| Nov 16 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 |